Inside the research
ICU Medical, Inc.
ICUI Research profile · latest available data
Price overview
$164.95
▼ -1.07 (-0.6%)
| 52w hi | $187.26 |
|---|---|
| 52w lo | $114.13 |
| Vol | 201.70K |
| As of | 25 Sep 2026 |
The Verdict
Our score +0.03
| Short | +0.14 |
|---|---|
| Medium | +0.10 |
| Long | -0.35 |
computed 2026-09-27
Key fundamentals
ICU Medical, Inc.
Healthcare · Medical Instruments & Supplies
| Market cap | $4.12B |
|---|---|
| Enterprise value | $5.11B |
| Trailing P/E | 138.61x |
| Forward P/E | 17.10x |
| EV / EBITDA | 15.67x |
| P / S (ttm) | 1.91x |
| Profit margin | 1.4% |
| Return on equity | 1.4% |
| Revenue growth | +0.5% |
| Earnings growth | -46.9% |
| Debt / equity | 59.82 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | -0.02 | |
| Sector | +0.08 | |
| Technical | +0.08 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-09-27
Business overview
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
Risk Metrics
| Beta vs SPX | 1.03 |
|---|---|
| Corr SPX | 0.44 |
| Annual vol | 38.1% |
| Annual ret | +3.8% |
| Sharpe | 0.10 |
| Max DD | -41.2% |
Window: 504 trading days (504 obs)
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-08-06 | Earnings Release, Exhibits | read |
| 2026-05-18 | Bylaws Amendment, Shareholder Vote… | read |
| 2026-05-07 | Earnings Release, Exhibits | read |
| 2026-02-20 | Officer / Director Change, Exhibits | read |
| 2026-02-19 | Earnings Release, Exhibits | read |
| 2025-11-06 | Earnings Release, Exhibits | read |
| 2025-08-07 | Earnings Release, Exhibits | read |
| 2025-05-14 | Officer / Director Change, Shareholder Vote… | read |
| 2025-05-08 | Earnings Release, Exhibits | read |
| 2025-02-27 | Earnings Release, Exhibits | read |
| 2024-11-12 | Earnings Release, Exhibits | read |
| 2024-10-02 | Officer / Director Change | read |
Insider Trades
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-13 | Woolson Daniel | VP, GM-Infusion Capital | Sell | 5.42K | $982.26K |
| 2026-08-12 | Sousa Ben | Chief Information Officer | Sell | 2.25K | $401.21K |
| 2026-08-11 | Voigtlander Christian B. | Chief Operating Officer | Sell | 8.93K | $1.63M |
| 2026-08-11 | FINNEY ELISHA W | Sell | 378 | $68.98K | |
| 2026-05-22 | Woolson Daniel | President | Sell | 2.12K | $280.68K |
| 2026-05-14 | Sanzone Virginia Ruth | VP, General Counsel | Sell | 2.45K | $303.62K |
| 2026-05-13 | KENNEDY KOLLEEN T | Option exercise | 1.25K | — | |
| 2026-05-13 | Hernandez Laurie | Option exercise | 1.25K | — | |
| 2026-05-13 | FINNEY ELISHA W | Option exercise | 1.25K | — | |
| 2026-05-13 | Abbey Donald | Option exercise | 1.25K | — |
Flow & Concentration
| Insider 180d net | -$3.67M |
|---|---|
| Insider buys / sells | 0 / 6 |
| Insider bias | Sellers |
| 13F holders | 0 |
| Top-5 share | 0.0% |
| HHI | 0 (—) |
SEC Filings
The Long Run
FY 2009–2025 · 17 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $2.26B | +16.8% | |
| Gross profit | $822.04M | +14.8% | |
| Operating income | $22.82M | -3.6% | |
| Net income | $732.00K | -30.7% | |
| Cash from ops | $179.85M | +9.1% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $166.43 | $166.67 | $163.95 | $164.95 | 201.70K |
| Sep 24 | $163.12 | $167.67 | $163.08 | $166.02 | 380.10K |
| Sep 23 | $160.26 | $166.46 | $159.29 | $163.32 | 408.30K |
| Sep 22 | $157.64 | $163.57 | $156.01 | $160.98 | 276.00K |
| Sep 21 | $154.25 | $156.80 | $152.49 | $155.22 | 223.40K |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →